Results 31 to 40 of about 1,342,022 (369)

Inflammatory bowel disease [PDF]

Archives of Disease in Childhood, 2006
Twenty five per cent of inflammatory bowel disease presents in childhood. Growth and nutrition are key issues in the management with the aim of treatment being to induce and then maintain disease remission with minimal side effects. Only 25% of Crohn's disease presents with the classic triad of abdominal pain, weight loss, and diarrhoea.
R M, Beattie, N M, Croft, J M, Fell, N A, Afzal, R B, Heuschkel   +4 more
openaire   +2 more sources

Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan [PDF]

Intestinal Research, 2019
Background/Aims Tacrolimus is effective for refractory ulcerative colitis in adults, while data for children is sparse. We aimed to evaluate the effectiveness and safety of tacrolimus for induction and maintenance therapy in Japanese children with ...
Tadahiro Yanagi, Kosuke Ushijima, Hidenobu Koga, Takeshi Tomomasa, Hitoshi Tajiri, Reiko Kunisaki, Takashi Isihige, Hiroyuki Yamada, Katsuhiro Arai, Atsushi Yoden, Tomoki Aomatsu, Satoru Nagata, Keiichi Uchida, Yoshikazu Ohtsuka, Toshiaki Shimizu   +14 more
doaj   +1 more source

The burden of inflammatory bowel disease in Europe in 2020.

Journal of Crohn's & Colitis, 2021
New data suggest that incidence and prevalence of inflammatory bowel diseases (IBD) are still increasing worldwide, and approximately 0.2% of the European population suffers from IBD at the present time.
Mirabella Zhao, L. Gönczi, P. Lakatos, J. Burisch   +3 more
semanticscholar   +1 more source

Associations between Pouchitis and Fecal Calprotectin after Restorative Proctocolectomy in Patients with Ulcerative Colitis

Inflammatory Intestinal Diseases, 2023
Introduction: Recently, fecal calprotectin has been identified and used as an assessment tool for the confirmation of disease activity in ulcerative colitis.
Motoi Uchino, Yuki Horio, Ryuichi Kuwahara, Kurando Kusunoki, Kentaro Nagano, Hiroki Ikeuchi   +5 more
doaj   +1 more source

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Gut, 2019
Ulcerative colitis and Crohn’s disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and ...
C. Lamb, C. Lamb, N. Kennedy, T. Raine, P. Hendy, P. Hendy, Philip J. Smith, J. Limdi, J. Limdi, B. Hayee, BuʼHussain Hayee, M. Lomer, M. Lomer, G. Parkes, G. Parkes, C. Selinger, C. Selinger, K. Barrett, R. Davies, Cathy Bennett, Stuart Gittens, M. Dunlop, M. Dunlop, O. Faiz, A. Fraser, V. Garrick, Paul D Johnston, M. Parkes, J. Sanderson, J. Sanderson, H. Terry, D. Gaya, D. Gaya, T. Iqbal, T. Iqbal, S. Taylor, S. Taylor, Melissa A. Smith, Melissa A. Smith, M. Brookes, R. Hansen, A. Hawthorne   +41 more
semanticscholar   +1 more source

The four epidemiological stages in the global evolution of inflammatory bowel disease

Nature reviews: Gastroenterology & hepatology, 2020
Inflammatory bowel disease (IBD) is a global disease; its evolution can be stratified into four epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence and Prevalence Equilibrium.
G. Kaplan, J. Windsor
semanticscholar   +1 more source

Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.

Gastroenterology, 2021
Inflammatory bowel diseases (IBD) are systemic disease that manifest not only in the gut/GI tract but also in many patients in extraintestinal organs.
G. Rogler, A. Singh, A. Kavanaugh, D. Rubin   +3 more
semanticscholar   +1 more source

Inflammatory Bowel Disease [PDF]

Evolution, Medicine, and Public Health, 2014
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic, relapsing inflammatory condition of the gastrointestinal tract. CD and UC have distinct pathologic and clinical characteristics and despite the extensive amount of research conducted over the past decades, their pathogenesis remains still poorly ...
Lee, Shona J., Maizels, Rick M.
openaire   +5 more sources

Rectal-sparing type of ulcerative colitis predicts lack of response to pharmacotherapies

BMC Surgery, 2017
Background Ulcerative colitis (UC) is known as an immune disorder of the colon that generally involves the rectum, but an atypical distribution of inflamed mucosa has previously been noted in certain subtypes of UC, such as the rectal-sparing type (RST).
Yuki Horio, Motoi Uchino, Toshihiro Bando, Teruhiro Chohno, Hirofumi Sasaki, Akihiro Hirata, Yoshio Takesue, Hiroki Ikeuchi   +7 more
doaj   +1 more source

The Use of Oral Herbal Medicine (Hange-Shashin-To) in Patients with Pouchitis: A Pilot Study

Journal of the Anus, Rectum and Colon, 2018
Objectives: Hange-Shashin-To (HST), which is a combination of seven herbs, has previously been used in the treatment of inflammatory or ulcerative gut disease.
Hiroki Matsuoka, Motoi Uchino, Yuki Horio, Hirofumi Sasaki, Teruhiro Chohno, Akihiro Hirata, Toshihiro Bando, Takashi Ito, Toshimasa Yamaguchi, Hiroki Ikeuchi   +9 more
doaj   +1 more source